francine blumental de abreu - PHL © Elysio - FUNDAÇÃO ANTÔNIO ...

233
Khusial PR, Vadla B, Krishnan H, et al. Src activates Abl to augment Robo1
expression in order to promote tumor cell migration. Oncotarget 2010;
1:198-209.
Kilpivaara O, Laiho P, Aaltonen LA, Nevanlinna H. CHEK2 1100delC and
colorectal cancer. J Med Genet 2003; 40:e110.
Klarskov L, Holck S, Bernstein I, Nilbert M. Hereditary colorectal câncer
diagnostics: morphological features of familial colorectal cancer type X
versus Lynch syndrome. J Clin Pathol 2012; 65:352-6.
Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma.
Proc Natl Acad Sci U S A 1971; 68:820-3.
Koh PK, Kalady M, Skacel M, et al. Familial colorectal cancer type X: polyp
burden and cancer risk stratification via a family history score. ANZ J Surg
2011; 81:537-42.
Komatsu A, Nagasaki K, Fujimori M, Amano J, Miki Y. Identification of novel
deletion polymorphisms in breast cancer. Int J Oncol 2008; 33:261-70.
Koon HB, Ippolito GC, Banham AH, Tucker PW. FOXP1: a potential
therapeutic target in cancer. Expert Opin Ther Targets 2007; 11:955-65.
Krepischi AC, Achatz MI, Santos EM, et al. Germline DNA copy number
variation in familial and early-onset breast cancer. Breast Cancer Res
2012a; 14:R24.
Krepischi AC, Pearson PL, Rosenberg C. Germline copy number variations
and cancer predisposition. Future Oncol 2012b; 8:441-50.